Efficacy of locally prepared inactivated combined vaccine of Salmonella enteritidis, Salmonella typhimurium, Avian influenza (H9N2) and Newcastle disease viruses

被引:0
|
作者
El-Maghraby, Abeer S. [1 ]
Abdelaziz, Wafaa R. [2 ]
Abd El-Moneam, M. M. [2 ]
Helal, A. M. [1 ]
机构
[1] Cent Lab Evaluat Vet Biol, Cairo, Egypt
[2] VSVRI, Cairo, Egypt
来源
BIOSCIENCE RESEARCH | 2019年 / 16卷 / 02期
关键词
S; enteritidis; typhimurium; Avian influenza (H9N2) virus; Newcastle disease virus; Efficacy; monovalent; vaccine; tetravalent; PREVALENCE; PROTECTION; INFECTION; CHICKEN; STRAIN;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study was conducted to prepare and evaluate the potency of a tetravalent inactivated vaccine for protection of chickens against Salmonella typhimurium, Salmonellaenteritidis, Al-H9N2 and Newcastle disease virus using Montanide ISA-70 VG as an oil adjuvant. The humeral immune response against S. typhimurium and S. enteritidis increased quickly by the 1st wpv, where the mean Log(2) antibody titers were (40 and 20) as measured by micro agglutination test and continue after boostering reached (1280 and 640) in monovalent and tetravalent prepared S. typhimurium, S. enteritidis vaccines on 4th wpb, respectively. S. typhimurium and S. enteritidis monovalent and tetravalent vaccines induced (83.3%, 80% and 86.3%) protection percent in challenged vaccinated birds, respectively. Also the vaccines stimulated the production of specific antibodies against Al-H9N2 and NDV as fast as 1stwpv. Then specific Al-H9N2 mean Log(2) HI antibody titers were (8.6 and 8.8 Log2) at the 4th wpv in monovalent and tetravalent Al-H9N2 vaccines, respectively just before boostering, After that the titer increase gradually reaching (9.4 and 9.8 Log2) at the 4th wpb. NDV mean Log2 HI antibodies titers at the 4th wpb was (11.2 Log2) in tetravalent NDV vaccine than monovalent vaccines was (10.6 Log2). On the other hand, the protection percent for Al-H9N2 and NDV monovalent and tetravalent vaccines reached 100% without any clinical signs observed, while the control+ve unvaccinated group post challenge with Al-H9N2 showed gasping, coughing, nasal and ocular discharge, depression, inappetance, weakness and were relactant to move with 30% mortality. Also, NDV control+ve unvaccinated group showed greenish diarrhia, depression, conjunctivities and nervous manifestations with 90% mortality approving the efficacy of the prepared vaccines. It could be concluded from our study that the tetravalent prepared vaccine can reduce AIV-H9N2, NDV, S.typhimurium and S. enteritidis infections reducing the load on the poultry sector by reducing stress for the worker and the birds.
引用
收藏
页码:1668 / 1678
页数:11
相关论文
共 50 条
  • [21] Contribution of Segment 3 to the Acquisition of Virulence in Contemporary H9N2 Avian Influenza Viruses
    Clements, Anabel L.
    Sealy, Joshua E.
    Peacock, Thomas P.
    Sadeyen, Jean-Remy
    Hussain, Saira
    Lycett, Samantha J.
    Shelton, Holly
    Digard, Paul
    Iqbal, Munir
    JOURNAL OF VIROLOGY, 2020, 94 (20)
  • [22] Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies)
    Gharaibeh, Saad
    Amareen, Shadi
    AVIAN DISEASES, 2015, 59 (04) : 508 - 511
  • [23] FIELD APPLICATION FOR EXPERIMENTAL INACTIVATED MULTIVALENT P-multocida AND AVIAN INFLUENZA (H9N2) VACCINE IN POULTRY
    Salama, Selim S.
    Abdelhady, Heba A.
    Atia, Lamiaa
    SLOVENIAN VETERINARY RESEARCH, 2019, 56 : 789 - 795
  • [24] Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
    Yang, Wenhao
    Dai, Jing
    Liu, Jingjing
    Guo, Mengjiao
    Liu, Xiaowen
    Hu, Shunlin
    Gu, Min
    Hu, Jiao
    Hu, Zenglei
    Gao, Ruyi
    Liu, Kaituo
    Chen, Yu
    Liu, Xiufan
    Wang, Xiaoquan
    VIRUSES-BASEL, 2022, 14 (05):
  • [25] Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine
    Ducatez, Mariette F.
    Becker, Jens
    Freudenstein, Astrid
    Delverdier, Maxence
    Delpont, Mattias
    Sutter, Gerd
    Guerin, Jean-Luc
    Volz, Asisa
    VETERINARY MICROBIOLOGY, 2016, 189 : 59 - 67
  • [26] Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea
    Lee, Dong-hun
    Fusaro, Alice
    Song, Chang-Seon
    Suarez, David L.
    Swayne, David E.
    VIROLOGY, 2016, 488 : 225 - 231
  • [27] The molecular basis of antigenic variation among A(H9N2) avian influenza viruses
    Peacock, Thomas P.
    Harvey, William T.
    Sadeyen, Jean-Remy
    Reeve, Richard
    Iqbal, Munir
    EMERGING MICROBES & INFECTIONS, 2018, 7
  • [28] Comparison of immunoadjuvant activities of four bursa! peptides combined with H9N2 avian influenza virus vaccine
    Zhang, Cong
    Zhou, Jiangfei
    Liu, Zhixin
    Liu, Yongqing
    Cai, Kairui
    Shen, Tengfei
    Liao, Chengshui
    Wang, Chen
    JOURNAL OF VETERINARY SCIENCE, 2018, 19 (06) : 817 - 826
  • [29] A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus
    Xu, Xiaohong
    Xue, Cong
    Liu, Xinxin
    Li, Junjiao
    Fei, Yidong
    Liu, Zhe
    Mu, Jiaqi
    Bi, Yuhai
    Qian, Jing
    Yin, Renfu
    Ding, Zhuang
    VETERINARY MICROBIOLOGY, 2019, 228 : 173 - 180
  • [30] Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken
    Ingrao, Fiona
    Ngabirano, Eva
    Rauw, Fabienne
    Dauphin, Gwenaelle
    Lambrecht, Benedicte
    VACCINE, 2024, 42 (15) : 3410 - 3419